Project Grant HT9425261E418
Award Date 8/15/26
Completion Date 8/14/30
Dollars Obligated $3.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Wisconsin–Madison a $1,074,650 project grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with an ultimate completion date of August 31, 2029. The grant supports investigation of the immunomodulatory effects of chemokine signaling in renal cell carcinoma, representing a hypothesis-driven biomedical research initiative designed to advance innovative...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $729,778 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning June 1, 2025 and concluding May 31, 2028. The award supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting—research aimed at identifying and developing novel diagnostic markers and treatment approaches through comprehensive molecular...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $777,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2028. This award supports a multiomic analysis research initiative focused on liquid biopsies for biomarker discovery and therapeutic targeting. The project will deliver advanced biomedical research capabilities aimed at identifying and...
- Federal Grant Award Summary The University of Wisconsin – Madison received a $855,185 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025 and concluding August 31, 2028. This award funds research to elucidate the role of cross-talk between sensory neurons and malignant cells via CGRP-RAMP1 signaling in melanoma progression. The research will deliver hypothesis-driven biomedical investigation...
- Federal Grant Award Summary The University of Wisconsin – Madison received a $500,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with performance through July 31, 2027. The project delivers research and development services focused on developing and testing a novel immune inhibitory transgene for delivery to vascular composite allografts during normothermic preservation. The primary objective...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $10,824,505.00 to the University of Wisconsin System to conduct research on cell-matrix interactions promoting idiopathic pulmonary fibrosis. The 4-year project, beginning June 1, 2024, will explore innovative approaches to studying the effects of aberrant collagen morphology on myofibroblast and macrophage activation in idiopathic pulmonary fibrosis. As part...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $465,935 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The project, titled "Combining 225Ac-PSMA and BRD4 Disruption to Overcome Resistance in Advanced Prostate Cancer," supports biomedical research aimed at developing novel therapeutic approaches for treatment-resistant prostate...
- Federal Grant Award Summary The University of Washington's Office of Sponsored Programs received a $498,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, through July 31, 2028. The grant supports research investigating anti-dystrophin T cell responses in patients with Duchenne muscular dystrophy (DMD), a progressive genetic muscle disorder affecting the military-relevant population....
- This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
- Federal Project Grant Award Summary The University of Wisconsin-Madison received a $1.23M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2028. The award supports research focused on developing PET/CT (Positron Emission Tomography/Computed Tomography) radiotracers labeled with Calcium-9 (Ca9) to identify high-risk patients with clear cell renal cell carcinoma. This...